| Drug Name |
Thiabendazole |
| Drug ID |
BADD_D02196 |
| Description |
2-Substituted benzimidazole first introduced in 1962. It is active against a variety of nematodes and is the drug of choice for strongyloidiasis. It has CNS side effects and hepatototoxic potential. (From Smith and Reynard, Textbook of Pharmacology, 1992, p919) |
| Indications and Usage |
For the treatment of strongyloidiasis (threadworm), cutaneous larva migrans (creeping eruption), visceral larva migrans, and trichinosis. |
| Marketing Status |
approved; vet_approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB00730
|
| KEGG ID |
D00372
|
| MeSH ID |
D013827
|
| PubChem ID |
5430
|
| TTD Drug ID |
D08QCJ
|
| NDC Product Code |
68022-7046; 51927-2278; 59014-0050; 49452-7723 |
| UNII |
N1Q45E87DT
|
| Synonyms |
Thiabendazole | Tiabendazol | Thibendole | 2-(4'-Thiazolyl)Benzimidazole | Mintezol | Omnizole | Mintesol |
